Gilead Sciences

U.S. Gains COVID-19 Drug Monopoly for Gilead’s 31,900% Markup

U.S. Gains COVID-19 Drug Monopoly for Gilead’s 31,900% Markup

July 1, 2020

Gilead Sciences Stock Is Rallying – And the Reason Why May Sicken You

June 29, 2020

The Stock Market Is Insane to Rally on Gilead’s Flimsy Remdesivir Study

April 29, 2020

Why Your Favorite ‘Coronavirus Stock’ Just Took Wall Street on a Nasty Ride

April 23, 2020

Dow Swings Wildly After Trial ‘Flop’ Ignites Coronavirus Drug Fears

April 23, 2020

This Is Why the Dow Jones Soared While Its 2 Biggest Stocks Dove

April 17, 2020

Why It’s Too Early to Celebrate Gilead Sciences’ Coronavirus Therapy

April 17, 2020